Zeluff 1988.
Methods | Randomized | |
Participants | Adults (mean age: 31; all South‐African black gold miners) Hospitalized Pneumococcal pneumonia per chest X‐ray and sputum (analyzed only culture positive) | |
Interventions | Atypical: PO roxithromycin 150 mg X 2/d Non‐atypical: PO cephradine 1 G X 2/d | |
Outcomes | Clinical response (= improvement of signs and symptoms and resolution of lung infiltrate) | |
Notes | Pneumococcal pneumonia in a young homogenous group | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | An allocation schedule of random numbers |
Allocation concealment (selection bias) | Unclear risk | Not identified |
Incomplete outcome data (attrition bias) Mortality | High risk | 158/160 participants evaluated |
Incomplete outcome data (attrition bias) Failure | High risk | 90/160 participants evaluated |
Selective reporting (reporting bias) | Low risk | Not identified |
Other bias | Unclear risk | ? sponsored |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double‐blind |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Double‐blind |
ABX: antibiotics CAP: community‐acquired pneumonia COPD: chronic obstructive pulmonary disease IM: intramuscular ITT: intention‐to‐treat IV: intravenous LD: loading dose PO: per oral RTI: respiratory tract infection s/e: side effects 1/d: once a day 2/d: two times a day 3/d: three times a day 4/d: four times a day